Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study

Henner Stege, Carmen Loquai, Michael Schultheis et al.|Cancers|2021

Cited by 23